APA (7th ed.) Citation

Szemerédi, N., Schelz, Z., Horvath, D. A., Rácz, B., Szatmári, A. G., Muddather, H. F., . . . Spengler, G. (2024). Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines. Pharmaceutics, 16(7), 877. https://doi.org/10.3390/pharmaceutics16070877

Chicago Style (17th ed.) Citation

Szemerédi, Nikoletta, Zsuzsanna Schelz, Dária Antónia Horvath, Bálint Rácz, András G. Szatmári, Hiba F. Muddather, Noémi Bózsity, István Zupkó, and Gabriella Spengler. "Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines." Pharmaceutics 16, no. 7 (2024): 877. https://doi.org/10.3390/pharmaceutics16070877.

MLA (9th ed.) Citation

Szemerédi, Nikoletta, et al. "Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines." Pharmaceutics, vol. 16, no. 7, 2024, p. 877, https://doi.org/10.3390/pharmaceutics16070877.